heartdisease

Heart Disease

1 Years ago

Chest pain drug falls short in preventing first episode of ventricular arrhythmia or death: But, drug found to reduce recurrent ventricular tachycardia in major multi-center trial

A trial of more than 1,000 patients with implantable cardioverter defibrillators found that the drug ranolazine (used to treat chest pain; brand name Ranexa (R)) was safe but didn't decrease the likelihood of the first occurrence of ventricular arrhythmias or death in this high-risk population. The drug did lower the risk for recurrent ventricular tachycardia by 30 percent, suggesting it could be a treatment option for this very sick population for which t..

  • 0 Likes

  • 0 Comments